In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Novo Nordisk A/S. Trade Record

NYSE:NVO Novo Nordisk A/S stock gains 5.26% Exit Jun 20, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart NVO Jun 5, 2019, priceSeries
About Novo Nordisk A/S

Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity Care, and Biopharmaceuticals. The Diabetes and Obesity Care segment provides insulins, GLP-1 analog, and oral anti-diabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through distributors and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.

Trade Information
Trade Type
LONG
ReliabilityScore™
76.26
Entry Date
Jun 5, 2019
Entry Price
48.22
Sell Date
Jun 20, 2019
Sell Price
50.76
Net Gain
5.26%
Hold Time
11 Trading Days